6901 — Diamond Biofund Cashflow Statement
0.000.00%
Last trade - 00:00- TWD34.27bn
- TWD27.58bn
- -TWD2.44bn
Annual cashflow statement for Diamond Biofund, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -371 | 6,091 | 2,961 | 881 | -2,584 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 304 | -6,500 | -3,062 | -1,005 | 2,452 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 16.6 | 133 | -211 | 586 | -2,446 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -39.6 | -263 | -300 | 473 | -2,568 |
| Capital Expenditures | -1.48 | 0 | — | -2.05 | -19.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 61.2 | -115 | 115 | 4.53 | -7.12 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 59.8 | -115 | 115 | 2.48 | -26.6 |
| Financing Cash Flow Items | — | — | — | — | 5.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.1 | -9.32 | -16.8 | -160 | 4,363 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.1 | -388 | -202 | 316 | 1,769 |